These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26516161)

  • 41. Potential therapies for residual hepatoblastoma following incomplete ablation treatment in a nude mouse subcutaneous xenograft model based on lncRNA and mRNA expression profiles.
    Wang XD; Peng JB; Zhou CY; Que Q; Li HY; He Y; Yang H
    Oncol Rep; 2020 Jun; 43(6):1915-1927. PubMed ID: 32186781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors.
    Sangkhathat S; Kusafuka T; Miao J; Yoneda A; Nara K; Yamamoto S; Kaneda Y; Fukuzawa M
    Int J Oncol; 2006 Mar; 28(3):715-22. PubMed ID: 16465377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells.
    Ai HH; Zhou ZL; Sun LG; Yang MT; Li W; Yu CL; Song ZB; Huang YX; Wu Y; Liu L; Yang XG; Zhao YQ; Bao YL; Li YX
    Apoptosis; 2017 Nov; 22(11):1404-1418. PubMed ID: 28864870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNA.
    Zhu Q; Hu Y; Jiang W; Ou ZL; Yao YB; Zai HY
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):175-197. PubMed ID: 37866478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
    Hsiao CC; Kao YH; Huang SC; Chuang JH
    Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
    Kang Q; Gong J; Wang M; Wang Q; Chen F; Cheng KW
    J Agric Food Chem; 2019 Dec; 67(50):13939-13947. PubMed ID: 31769973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
    Kolorz J; Demir S; Gottschlich A; Beirith I; Ilmer M; Lüthy D; Walz C; Dorostkar MM; Magg T; Hauck F; von Schweinitz D; Kobold S; Kappler R; Berger M
    Curr Oncol; 2021 Dec; 29(1):94-110. PubMed ID: 35049682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.
    Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T
    J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.
    Akiva I; Birgül Iyison N
    BMC Cancer; 2018 Jan; 18(1):60. PubMed ID: 29310626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice.
    Tumova L; Pombinho AR; Vojtechova M; Stancikova J; Gradl D; Krausova M; Sloncova E; Horazna M; Kriz V; Machonova O; Jindrich J; Zdrahal Z; Bartunek P; Korinek V
    Mol Cancer Ther; 2014 Apr; 13(4):812-22. PubMed ID: 24552772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of tachykinin NK
    Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma.
    Li L; Wu Y; Huang HT; Yong JK; Lv Z; Zhou Y; Xiang X; Zhao J; Xi Z; Feng H; Xia Q
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):377. PubMed ID: 39085725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.
    López-Terrada D; Gunaratne PH; Adesina AM; Pulliam J; Hoang DM; Nguyen Y; Mistretta TA; Margolin J; Finegold MJ
    Hum Pathol; 2009 Jun; 40(6):783-94. PubMed ID: 19200579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a drug resistance model for hepatoblastoma.
    Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Int J Oncol; 2011 Feb; 38(2):447-54. PubMed ID: 21132272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.
    Armengol C; Cairo S; Fabre M; Buendia MA
    Int J Biochem Cell Biol; 2011 Feb; 43(2):265-70. PubMed ID: 19646548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.